North America Aesthetic Injectable Devices Market Size and Forecast (2021

List of Tables

The North America aesthetic injectable devices market is projected to grow from US$ 5,606.7 million in 2024 to US$ 9,657.8 million by 2031, registering a CAGR of 8.2% during 2025-2031.

Executive Summary & Market Overview:

The market in North America-comprising the US, Canada, and Mexico-is expected to hold a substantial share globally. Growth is largely driven by increasing demand for minimally invasive cosmetic procedures. As awareness of personal appearance and self-care rises, more individuals are opting for non-surgical treatments such as Botox and dermal fillers to enhance facial features and reduce signs of aging. The region benefits from advanced healthcare infrastructure and a strong presence of qualified dermatologists and plastic surgeons, supporting widespread adoption. Early access to innovative technologies and products further strengthens market expansion.

Social media and celebrity influence have also normalized cosmetic enhancements, encouraging uptake across diverse age groups. Higher disposable incomes and the growing number of med spas and aesthetic clinics have improved accessibility. Additionally, an aging population seeking effective anti-aging solutions continues to sustain demand.

Segmentation Insights:

By product, botulinum toxin dominated the market in 2024, followed by dermal fillers and others.

Within dermal fillers, hyaluronic acid accounted for the largest share.

By device, pre-filled syringes led the segment.

By application, facial line correction held the top position.

By age group, individuals aged 31-40 represented the largest segment.

By gender, females dominated the market.

By end user, dermatology clinics accounted for the highest share.

Market Outlook:

A key emerging trend is regenerative aesthetics, which focuses on stimulating the body's natural healing processes to achieve long-lasting and natural-looking results. Techniques such as platelet-rich plasma (PRP), biostimulatory fillers, and exosome-based therapies enhance collagen production, improving skin elasticity and rejuvenation.

Innovations like Sculptra and advanced treatments such as Morpheus8 are reshaping anti-aging approaches by combining collagen stimulation with skin-tightening technologies. These methods offer non-surgical solutions with noticeable improvements in skin firmness and texture.

As collagen levels naturally decline with age, treatments that promote collagen and elastin production are gaining popularity. Research indicates that combining biostimulatory fillers with radiofrequency microneedling can significantly improve skin density and firmness within months. This shift toward regenerative and preventive treatments is expected to redefine consumer expectations and drive further market growth.

Country Insights:

The United States led the market in 2024, supported by a surge in noninvasive aesthetic procedures and continuous innovation. Millions of cosmetic procedures are performed annually, with injectables accounting for a significant share. Consumers increasingly favor subtle, natural-looking results, boosting spending on aesthetic treatments.

The market is also benefiting from frequent product launches and regulatory approvals. Companies are introducing advanced solutions, including augmented reality tools for treatment visualization and new injectable formulations designed for longer-lasting and more natural outcomes. These developments are reinforcing market expansion in the US.

Key Market Players:

Leading companies include Merz Pharma, AbbVie, Ipsen, Mesoestetic, Galderma, Revance Therapeutics, Medytox, Sinopharm Group, Evolus, Hugel, Sinclair Pharma, and Laboratoires Vivacy. These players focus on innovation, expansion, and strategic collaborations to strengthen their market position.

Product Code: TIPRE00041909

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

5. Europe Aesthetic Injectable Devices Market - Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:

6. Aesthetic Injectable Devices Market - Europe Market Analysis

6.1 Europe Aesthetic Injectable Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Aesthetic Injectable Devices Market Forecast and Analysis

7. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Product

7.1 Dermal Filler
- 7.1.1 Overview
- 7.1.2 Dermal Filler: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Botulinum Toxin
- 7.2.1 Overview
- 7.2.2 Botulinum Toxin: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Others
- 7.3.1 Overview
- 7.3.2 Others: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Dermal Fillers

8.1 Calcium Hydroxylapatite
- 8.1.1 Overview
- 8.1.2 Calcium Hydroxylapatite: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Hyaluronic Acid
- 8.2.1 Overview
- 8.2.2 Hyaluronic Acid: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Collagen
- 8.3.1 Overview
- 8.3.2 Collagen: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Poly-L-Lactic Acid
- 8.4.1 Overview
- 8.4.2 Poly-L-Lactic Acid: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Polymethylmethacrylate (PMMA)
- 8.5.1 Overview
- 8.5.2 Polymethylmethacrylate (PMMA): Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Fat Fillers
- 8.6.1 Overview
- 8.6.2 Fat Fillers: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Device

9.1 Microcannulas
- 9.1.1 Overview
- 9.1.2 Microcannulas: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Pre-Filled Syringes
- 9.2.1 Overview
- 9.2.2 Pre-Filled Syringes: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Mesotherapy Guns
- 9.3.1 Overview
- 9.3.2 Mesotherapy Guns: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Application

10.1 Facial Line Correction
- 10.1.1 Overview
- 10.1.2 Facial Line Correction: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Face Lift
- 10.2.1 Overview
- 10.2.2 Face Lift: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Lip Treatment
- 10.3.1 Overview
- 10.3.2 Lip Treatment: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Anti-Ageing and Wrinkle Treatment
- 10.4.1 Overview
- 10.4.2 Anti-Ageing and Wrinkle Treatment: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Acne and Scar Treatment
- 10.5.1 Overview
- 10.5.2 Acne and Scar Treatment: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Stretch Marks
- 10.6.1 Overview
- 10.6.2 Stretch Marks: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Age Group

11.1 Up to 30
- 11.1.1 Overview
- 11.1.2 Up to 30: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 31-40
- 11.2.1 Overview
- 11.2.2 31-40: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 41-50
- 11.3.1 Overview
- 11.3.2 41-50: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 51-60
- 11.4.1 Overview
- 11.4.2 51-60: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.5 More Than 60
- 11.5.1 Overview
- 11.5.2 More Than 60: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Europe Aesthetic Injectable Devices Market Revenue Analysis - by Gender

12.1 Female
- 12.1.1 Overview
- 12.1.2 Female: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Male
- 12.2.1 Overview
- 12.2.2 Male: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Europe Aesthetic Injectable Devices Market Revenue Analysis - by End User

13.1 Medical Spas
- 13.1.1 Overview
- 13.1.2 Medical Spas: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Dermatology Clinics
- 13.2.1 Overview
- 13.2.2 Dermatology Clinics: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Hospitals
- 13.3.1 Overview
- 13.3.2 Hospitals: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.4 Others
- 13.4.1 Overview
- 13.4.2 Others: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

14. Europe Aesthetic Injectable Devices Market - Country Analysis

14.1 Europe
- 14.1.1 Europe Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 14.1.1.1 Europe Aesthetic Injectable Devices Market Revenue and Forecast and Analysis - by Country
  - 14.1.2.2 Germany: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.1.2.2.1 Germany: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.1.2.2.2 Germany: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.1.2.2.3 Germany: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.1.2.2.4 Germany: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.1.2.2.5 Germany: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.1.2.2.6 Germany: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.1.2.2.7 Germany: Europe Aesthetic Injectable Devices Market Share - by End User
  - 14.2.3.3 United Kingdom: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.2.3.3.1 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.2.3.3.2 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.2.3.3.3 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.2.3.3.4 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.2.3.3.5 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.2.3.3.6 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.2.3.3.7 United Kingdom: Europe Aesthetic Injectable Devices Market Share - by End User
  - 14.3.4.4 France: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.3.4.4.1 France: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.3.4.4.2 France: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.3.4.4.3 France: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.3.4.4.4 France: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.3.4.4.5 France: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.3.4.4.6 France: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.3.4.4.7 France: Europe Aesthetic Injectable Devices Market Share - by End User
  - 14.4.5.5 Spain: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.4.5.5.1 Spain: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.4.5.5.2 Spain: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.4.5.5.3 Spain: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.4.5.5.4 Spain: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.4.5.5.5 Spain: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.4.5.5.6 Spain: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.4.5.5.7 Spain: Europe Aesthetic Injectable Devices Market Share - by End User
  - 14.5.6.6 Italy: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.5.6.6.1 Italy: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.5.6.6.2 Italy: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.5.6.6.3 Italy: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.5.6.6.4 Italy: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.5.6.6.5 Italy: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.5.6.6.6 Italy: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.5.6.6.7 Italy: Europe Aesthetic Injectable Devices Market Share - by End User
  - 14.6.7.7 Rest of Europe: Europe Aesthetic Injectable Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 14.6.7.7.1 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Product
    - 14.6.7.7.2 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Dermal Fillers
    - 14.6.7.7.3 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Device
    - 14.6.7.7.4 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Application
    - 14.6.7.7.5 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Age Group
    - 14.6.7.7.6 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by Gender
    - 14.6.7.7.7 Rest of Europe: Europe Aesthetic Injectable Devices Market Share - by End User

15 Competitive Landscape

15.1 Heat Map Analysis by Key Players
15.2 Company Positioning & Concentration

16 Industry Landscape

16.1 Overview
16.2 New Product Development
16.3 Merger and Acquisition
16.4 Other Strategic Developments

17 COMPANY PROFILES

17.1 Merz Pharma GmbH & Co KGaA
- 17.1.1 Key Facts
- 17.1.2 Business Description
- 17.1.3 Products and Services
- 17.1.4 Financial Overview
- 17.1.5 SWOT Analysis
- 17.1.6 Key Developments
17.2 AbbVie Inc
- 17.2.1 Key Facts
- 17.2.2 Business Description
- 17.2.3 Products and Services
- 17.2.4 Financial Overview
- 17.2.5 SWOT Analysis
- 17.2.6 Key Developments
17.3 Ipsen SA
- 17.3.1 Key Facts
- 17.3.2 Business Description
- 17.3.3 Products and Services
- 17.3.4 Financial Overview
- 17.3.5 SWOT Analysis
- 17.3.6 Key Developments
17.4 Mesoestetic E-Commerce SL
- 17.4.1 Key Facts
- 17.4.2 Business Description
- 17.4.3 Products and Services
- 17.4.4 Financial Overview
- 17.4.5 SWOT Analysis
- 17.4.6 Key Developments
17.5 Galderma SA
- 17.5.1 Key Facts
- 17.5.2 Business Description
- 17.5.3 Products and Services
- 17.5.4 Financial Overview
- 17.5.5 SWOT Analysis
- 17.5.6 Key Developments
17.6 Revance Therapeutics Inc
- 17.6.1 Key Facts
- 17.6.2 Business Description
- 17.6.3 Products and Services
- 17.6.4 Financial Overview
- 17.6.5 SWOT Analysis
- 17.6.6 Key Developments
17.7 Medytox Inc
- 17.7.1 Key Facts
- 17.7.2 Business Description
- 17.7.3 Products and Services
- 17.7.4 Financial Overview
- 17.7.5 SWOT Analysis
- 17.7.6 Key Developments
17.8 Sinopharm Group Co Ltd
- 17.8.1 Key Facts
- 17.8.2 Business Description
- 17.8.3 Products and Services
- 17.8.4 Financial Overview
- 17.8.5 SWOT Analysis
- 17.8.6 Key Developments
17.9 Evolus Inc
- 17.9.1 Key Facts
- 17.9.2 Business Description
- 17.9.3 Products and Services
- 17.9.4 Financial Overview
- 17.9.5 SWOT Analysis
- 17.9.6 Key Developments
17.10 Hugel Inc
- 17.10.1 Key Facts
- 17.10.2 Business Description
- 17.10.3 Products and Services
- 17.10.4 Financial Overview
- 17.10.5 SWOT Analysis
- 17.10.6 Key Developments
17.11 Sinclair Pharma Ltd
- 17.11.1 Key Facts
- 17.11.2 Business Description
- 17.11.3 Products and Services
- 17.11.4 Financial Overview
- 17.11.5 SWOT Analysis
- 17.11.6 Key Developments
17.12 Laboratoires Vivacy, S.A.S.
- 17.12.1 Key Facts
- 17.12.2 Business Description
- 17.12.3 Products and Services
- 17.12.4 Financial Overview
- 17.12.5 SWOT Analysis
- 17.12.6 Key Developments

18. Appendix

18.1 About The Insight Partners